about
Subcutaneous or intramuscular methotrexate for rheumatoid arthritisInterventions for periodontal disease in people with rheumatoid arthritisOfatumumab for rheumatoid arthritisAbatacept for rheumatoid arthritisQuantitative gait analysis as a method to assess mechanical hyperalgesia modulated by disease-modifying antirheumatoid drugs in the adjuvant-induced arthritic ratImproving healthcare consumer effectiveness: an Animated, Self-serve, Web-based Research Tool (ANSWER) for people with early rheumatoid arthritis.Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects.EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).Optimizing literature search in systematic reviews - are MEDLINE, EMBASE and CENTRAL enough for identifying effect studies within the area of musculoskeletal disorders?The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic DiseasesAdvances in and Algorithms for the Treatment of Relapsing-Remitting Multiple SclerosisAn update of teriflunomide for treatment of multiple sclerosis.Review of teriflunomide and its potential in the treatment of multiple sclerosis.Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis.Clinical effectiveness and safety of leflunomide in inflammatory arthritis: a report from the RAPPORT database with supporting patient survey.Changes in Body Mass Related to the Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis.
P2860
Q24187565-B0BAF483-4EAB-4D79-9405-76EF055DA5BBQ24200961-31FE08B7-4E8D-4E38-AD16-D85C484D95BAQ24202719-A303810C-6A50-4D76-A71F-9F02DF8A3925Q24242770-ACF5F162-BAF6-4E2B-9AD6-F9E19EAF7435Q28221343-C05665CC-8EED-4CA8-BB06-36E20D4634EAQ33495384-D3D269D3-025D-423F-9C80-B0A8FDFCDBBEQ34389332-A15C1E1D-C02B-400B-A02A-0E4C40BB4D6CQ35638360-2E4DC48A-A94A-4812-B941-3A6B9A15B71EQ36201358-B39EB252-DBF1-4CED-A634-D4842454A6CDQ36286414-6A785584-C26D-4A21-8542-7A66DE471532Q36484448-85B4FD6F-E6B0-4238-A539-8B3884119A2DQ36906008-F6ACDDC8-1EA9-4543-BFBC-064E628B8E9FQ37235715-E4991F24-5ED1-499D-8C4A-D37ACECBFB62Q37358239-F1B81461-263B-45E5-8AE4-C196BF8325FDQ38760596-50F133B0-2FA3-48D3-A25A-9C7C898EE056Q39993473-07AC9E82-8493-439F-BAD2-87250893ED64
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Leflunomide for treating rheumatoid arthritis.
@ast
Leflunomide for treating rheumatoid arthritis.
@en
type
label
Leflunomide for treating rheumatoid arthritis.
@ast
Leflunomide for treating rheumatoid arthritis.
@en
prefLabel
Leflunomide for treating rheumatoid arthritis.
@ast
Leflunomide for treating rheumatoid arthritis.
@en
P2093
P2860
P1476
Leflunomide for treating rheumatoid arthritis.
@en
P2093
P2860
P304
P356
10.1002/14651858.CD002047
P577
2003-01-01T00:00:00Z